Ready to play
Ready to play
An official from the Food and Drug Authority explained that the "Rare" program facilitates access to treatments for rare diseases through regulatory incentives, with the goal of improving the availability of these medications for patients. The program aims to reduce regulatory barriers and make it easier to bring rare drugs to market, thereby increasing patients' chances of receiving treatment more quickly and effectively.
Notice: This Is an AI-Generated Summary
Comments (0)